Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study

OBJECTIVES: Fat lesions (FLs) on MRI T1 sequences are considered to be early indicators of structural spinal progression in axial spondyloarthritis (axSpA) patients. In this post-hoc analysis from RAPID-axSpA, we assess whether tumour necrosis factor inhibitor (TNFi) treatment over 4 years impacts F...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraliakos, Xenofon, Kruse, Sebastian, Auteri, Simone E, de Peyrecave, Natasha, Nurminen, Tommi , Kumke, Thomas, Hoepken, Bengt, Braun, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258590/
https://www.ncbi.nlm.nih.gov/pubmed/34791107
http://dx.doi.org/10.1093/rheumatology/keab841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258590/
https://www.ncbi.nlm.nih.gov/pubmed/34791107
http://dx.doi.org/10.1093/rheumatology/keab841

Ejemplares similares